FBDIX

Franklin Biotechnology Discovery A
NasdaqUSDETF / FUND DELAYED
Last price
178.68
▼ 3.47 (1.91%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
182.15
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
—
52W range
155.12 – 213.76

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.15% -6.1%
1M
-13.25% -14.7%
3M
-12.23% -15.7%
6M
+4.50% -10.5%
YTD
+7.81% -6.2%
1Y
+17.17% +1.4%
3Y
+65.00% -16.9%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
JAZZ Jazz Pharmaceuticals PLC 5.06%
AMGN Amgen Inc 4.65%
ARGX argenx SE ADR 4.15%
GILD Gilead Sciences Inc 4.11%
VRTX Vertex Pharmaceuticals Inc 3.83%
REGN Regeneron Pharmaceuticals Inc 3.74%
RVMD Revolution Medicines Inc Ordinary Shares 3.13%
AZN.L AstraZeneca PLC 2.72%
ASND Ascendis Pharma AS 2.68%
AMLX Amylyx Pharmaceuticals Inc 2.57%

Sector exposure

Fund weightings
Healthcare
99.72%
Financial services
0.28%

Fund profile

As reported
Fund familyFranklin Templeton
CategoryHealth
Legal type—
Expense ratio1.01%
Turnover—
Total net assets—

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on FBDIX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
184.84
-3.33% from price
SMA 20
190.07
-5.99% from price
SMA 50
198.20
-9.85% from price
SMA 100
191.41
-6.65% from price
SMA 200
180.67
-1.10% from price
EMA 12
185.97
-3.92% from price
EMA 26
191.15
-6.52% from price
EMA 50
193.63
-7.72% from price
RSI (14)
26.2
Oversold
MACD (12,26,9)
-5.18
Hist -1.01
ATR (14)
2.07
1.16% of price
Realised vol 30D
20.8%
Annualised
Bollinger upper
201.82
20, 2σ
Bollinger lower
178.33
20, 2σ
50 / 200 cross
Golden
198.20 vs 180.67
Trend bias
Below 200
-1.10%

Options chain

Account required
Expiry
Spot 178.68
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.07
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
20.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-16.4%
Peak to trough
Max drawdown 5Y
-44.6%
Peak to trough
ATR 14
2.07
1.16% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.